Secukinumab gets one step closer to approval in Europe for treating psoriasis.

[jiml]

Just a small question reading the text they talk of first line systemic treatment and second line systemic treatment .
What does that mean in laymen's terms?

Looks like more good news for the future costs allowing ..............

Where's Matari when you need him.

I'll take a guess and say, they are suggesting instead of trying Remicade or Enbrel first it would be a good idea to try Secukinumab first.

But don't quote me on that.

I always thought that it is the first choice they will make.
So... You got psoriasis, you need systemic, ok here we gonna try blablamab first.
Like it previously would be MTX first, that is now shifting to payable biologicals (or DMF), then if those do not work, they shift to the more expensive and slightly different working dadaMAB's as the second line.

So there is progress. Slowly they begin to skip the medications that only make you sicker.

Thanks caroline it makes good sense and if a MAB is going to be frontline rather than methopoison well I'm all for it ...
We just have to get DMF more accepted ... It will happen